Sutro Biopharma, Inc. (STRO): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

$11.13M
Year ended 2018-12-31
2016-12-31: -$17.55M2017-12-31: -$40.39M2018-12-31: $11.13M$11.13M
2016-12-31 Free Cash Flow (USD) 2018-12-31
Period endedFree Cash FlowChange YoYSource filing
2018-12-31$11.13Mn/m2021-03-18, From 2018-01-01
2017-12-31-$40.39Mn/m2020-03-16, From 2017-01-01
2016-12-31-$17.55Mn/a2019-04-01, From 2016-01-01